Advanced in Epilepsy

Dr. Ronald G. Davis

Pediatric Neurology | Neurology
1245 W Fairbanks Ave Ste 305, 
Winter Park, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Advanced in Epilepsy
1245 W Fairbanks Ave Ste 305, 
Winter Park, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ronald Davis is a Pediatric Neurologist and a Neurologist in Winter Park, Florida. Dr. Davis is rated as an Advanced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Lennox-Gastaut Syndrome (LGS), Seizures, Dravet Syndrome, and Autosomal Dominant Partial Epilepsy with Auditory Features. Dr. Davis is currently accepting new patients.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles and participated in 6 clinical trials in the study of Epilepsy.

Specialties
Pediatric Neurology
Neurology
Licenses
Neurology with Special Qualifications in Neurology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

1245 W Fairbanks Ave Ste 305, Winter Park, FL 32789

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
Enrollment Status: Terminated
Publish Date: August 22, 2024
Intervention Type: Drug
Study Drug: JBPOS0101
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: April 04, 2024
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: May 30, 2023
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
View 6 Less Clinical Trials

8 Total Publications

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.
Journal: Epilepsy & behavior : E&B
Published: July 18, 2025
Similar Doctors
Distinguished in Epilepsy
Dr. Luis E. Bello-Espinosa
Pediatric Neurology | Neurology
Distinguished in Epilepsy
Dr. Luis E. Bello-Espinosa
Pediatric Neurology | Neurology
100 W Gore St Ste 600, 
Orlando, FL 
 (6.1 miles away)
321-841-3050
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Luis Bello-Espinosa is a Pediatric Neurologist and a Neurologist in Orlando, Florida. Dr. Bello-Espinosa is rated as an Advanced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Epilepsy, Seizures, West Syndrome, and Epilepsy Juvenile Absence. Dr. Bello-Espinosa is currently accepting new patients.

Distinguished in Epilepsy
Dr. Ahmed H. Sadek
Neurology
Distinguished in Epilepsy
Dr. Ahmed H. Sadek
Neurology

Orlando Epilepsy Center Inc

2881 Delaney Ave, Suite A, 
Orlando, FL 
 (6.3 miles away)
407-704-8510
Languages Spoken:
English, Arabic, Kannada
See accepted insurances
Accepting New Patients
Offers Telehealth

Ahmed Sadek is a Neurologist in Orlando, Florida. Dr. Sadek is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Memory Loss, and Landau-Kleffner Syndrome. Dr. Sadek is currently accepting new patients.

Distinguished in Epilepsy
Dr. Naga P. Nidadavolu
Neurology
Distinguished in Epilepsy
Dr. Naga P. Nidadavolu
Neurology
4739 Old Canoe Creek Rd, 
Saint Cloud, FL 
 (23.7 miles away)
Languages Spoken:
English, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Naga Nidadavolu is a Neurologist in Saint Cloud, Florida. Dr. Nidadavolu is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Andermann Syndrome, Septic Arthritis, Tomaculous Neuropathy, and Hereditary Sensory Neuropathy Type 1 (HSN1). Dr. Nidadavolu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Davis's expertise for a condition
ConditionClose
View All 26 Advanced Conditions
View All 116 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile